BRPI0721916A2 - Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas - Google Patents

Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas

Info

Publication number
BRPI0721916A2
BRPI0721916A2 BRPI0721916A BRPI0721916A2 BR PI0721916 A2 BRPI0721916 A2 BR PI0721916A2 BR PI0721916 A BRPI0721916 A BR PI0721916A BR PI0721916 A2 BRPI0721916 A2 BR PI0721916A2
Authority
BR
Brazil
Prior art keywords
therapeutic
color
preparation
methods
polymeric particles
Prior art date
Application number
Other languages
English (en)
Inventor
Ulf Fritz
Olaf Fritz
Thomas A Gordy
Ronald Wojcik
Jacques Blummel
Alexander Kuller
Original Assignee
Celonova Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celonova Biosciences Inc filed Critical Celonova Biosciences Inc
Publication of BRPI0721916A2 publication Critical patent/BRPI0721916A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/025Polyphosphazenes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/12Powdering or granulating
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D185/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Coating compositions based on derivatives of such polymers
    • C09D185/02Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Coating compositions based on derivatives of such polymers containing phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/36Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2385/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Derivatives of such polymers
    • C08J2385/02Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Derivatives of such polymers containing phosphorus
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
BRPI0721916 2007-07-25 2007-10-26 Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas BRPI0721916A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96201507P 2007-07-25 2007-07-25
PCT/US2007/082659 WO2009014549A1 (en) 2007-07-25 2007-10-26 Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

Publications (1)

Publication Number Publication Date
BRPI0721916A2 true BRPI0721916A2 (pt) 2015-05-05

Family

ID=39874122

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0721916 BRPI0721916A2 (pt) 2007-07-25 2007-10-26 Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas

Country Status (10)

Country Link
EP (2) EP2545906B1 (pt)
JP (2) JP2010534266A (pt)
KR (1) KR101506557B1 (pt)
CN (1) CN101820861A (pt)
AU (1) AU2007356895B2 (pt)
BR (1) BRPI0721916A2 (pt)
CA (1) CA2694408C (pt)
ES (1) ES2564151T3 (pt)
IL (1) IL203491B (pt)
WO (1) WO2009014549A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
WO2010091124A2 (en) 2009-02-03 2010-08-12 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
KR20200015814A (ko) * 2010-02-03 2020-02-12 마이크로비온 코포레이션 세균 균막의 치료 및 다른 용도를 포함하는, 생의학적 용도를 위한 방부제로서 비스무트-티올
US10383957B2 (en) 2015-01-06 2019-08-20 Anthony H. de Haas Near-infrared fluorescent surgical dye markers
CN107666861B (zh) * 2015-03-18 2022-03-01 皇家飞利浦有限公司 在利用尺寸不同的药物洗脱微球珠粒进行经动脉化疗栓塞之后的药物浓度确定
CN110382020A (zh) * 2016-12-28 2019-10-25 桑比欧公司 细胞递送系统及操作细胞递送系统的方法
CN110891550B (zh) * 2017-07-13 2023-03-07 瓦里安医疗系统公司 栓塞微球
AU2019315509B2 (en) 2018-07-31 2025-06-26 Microbion Corporation Bismuth-thiol compositions and methods of use
AU2019312592B2 (en) 2018-07-31 2025-06-26 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
JP7793513B2 (ja) * 2019-10-07 2026-01-05 ゲルベ 非分解性放射線不透過性塞栓ミクロスフェア
JP7665605B2 (ja) * 2019-10-07 2025-04-21 ゲルベ 非分解性の塞栓ミクロスフェア
CN111632561A (zh) * 2020-06-01 2020-09-08 南京林业大学 一种基于气辅法制备多面异向编码微球的方法及其应用
CN120437362B (zh) * 2025-07-11 2025-10-31 杭州汇瑞森生物科技有限公司 一种磷酸化氨基酸复合微球及其制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0351200A (ja) * 1989-07-20 1991-03-05 Maruishi Kasei Kk 絵具付パレット
GB9712525D0 (en) * 1997-06-16 1997-08-20 Nycomed Imaging As Method
CA2402949C (en) * 2000-03-18 2009-09-08 Polyzenix Gmbh Polyphosphazene derivatives having bacterial resistance and use thereof
EP1179353A1 (de) 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
US20040186437A1 (en) * 2003-03-20 2004-09-23 Frenette Claude E. Content-coded medical syringe, syringe set and syringe content identification method
EP1804773B1 (en) * 2004-10-25 2011-03-30 CeloNova BioSciences Germany GmbH Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
JP2005199723A (ja) * 2005-03-10 2005-07-28 Pilot Ink Co Ltd ボールペン用キャップ

Also Published As

Publication number Publication date
EP2545906A1 (en) 2013-01-16
JP5775912B2 (ja) 2015-09-09
EP2185132B1 (en) 2016-02-17
CN101820861A (zh) 2010-09-01
JP2014039836A (ja) 2014-03-06
WO2009014549A1 (en) 2009-01-29
EP2545906B1 (en) 2017-04-19
JP2010534266A (ja) 2010-11-04
KR101506557B1 (ko) 2015-03-30
CA2694408C (en) 2014-01-07
KR20100074109A (ko) 2010-07-01
EP2185132A1 (en) 2010-05-19
AU2007356895A1 (en) 2009-01-29
IL203491B (en) 2018-06-28
AU2007356895B2 (en) 2012-11-15
CA2694408A1 (en) 2009-01-29
ES2564151T3 (es) 2016-03-18

Similar Documents

Publication Publication Date Title
BRPI0721916A2 (pt) Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas
BRPI1016234A2 (pt) dispositivo aplicador para uso médico e/ou cosmético.
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0810524A2 (pt) Derivado de (aza)indol e uso do mesmo para propósitos médicos
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BRPI1010595A2 (pt) cateteres de aterectomia facilmente limpaveis e metodos para uso
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
IL241985A0 (en) Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI0807132A2 (pt) enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas
BR112015012644A2 (pt) método para determinar a necessidade de um paciente com câncer, método de tratamento do câncer, composição farmacêutica, uso de um ácido nucleico ou anticorpo e kit;
BRPI0812575A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, sequência de nucleotídeos
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0822092A2 (pt) Dispositivo sensor microeletrônico para o exame de partículas alvo, método para o exame das partículas alvo, e, uso do dispositivo sensor microeletrônico
BRPI0822997A2 (pt) Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos
BRPI1009860A2 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
BR112012000417A2 (pt) aparelho para uso em tratamento terapêutico e/ou cosmético
BRPI0819821A2 (pt) Preparação e uso de polianilinas para tratamento de água
BR112012027574A2 (pt) aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.